For cell and gene therapy applications, TekniPlex Healthcare produces and supplies tubing in a variety of configurations, grades and durometers. Both single- and multi-lumen constructions are available, as well as multi-layer versions incorporating complementary materials for performance optimization.
For traditional bioprocess applications, the company produces tight-tolerance biopharm-grade constructions comprised of TPE, TPV and silicones. Each of its offerings covers all stages of the drug development process, from small batch production through scale-up and commercial quantities.
The company will also highlight its coextrusion film capabilities, including newly expanded cleanroom manufacturing capacity for multilayer films suitable for single-use bioprocessing applications. The new ISO 7 cleanroom multilayer blown film line at the company’s Puurs, Belgium facility, joins existing cast coextrusion ISO 7 cleanroom manufacturing capacity suitable for bioprocessing bag film production. The additional film production expands capabilities to provide customizable film solutions to bioprocessing bag manufacturers, with a range of potential resin combinations helping meet durability needs, as well as extractables and leachables profile requirements.
“As the biologics sector continues its steady growth, so does the need for high-quality materials and components suppliers who can also be innovative solutions partners,’ said Chris Qualters, CEO of TekniPlex Healthcare. “With our expanding capacities and innovative mindset, TekniPlex Healthcare is poised and ready to respond to the evolving needs of the sector, providing value-added solutions that help bring life-changing therapies to market.”
https://www.contractpharma.com/contents/view_breaking-news/2024-03-12/tekniplex-healthcare-to-debut-bioprocessing-solutions-at-interphex/9769
PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a sharp focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.
Related News
Skyline Therapeutics Receives FDA Orphan Drug Designation for Gene Therapy for Retinitis Pigmentosa
BOSTON & SHANGHAI, September 2, 2024 – Skyline Therapeutics, a gene therapy company focused on innovative treatments for rare and severe diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for SKG1108....
Novavax Receives Emergency Use Authorization for Updated Covid-19 Vaccine
Novavax has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its updated Covid-19 vaccine, NVX-CoV2705, joining other vaccine manufacturers in addressing evolving virus variants. The EUA permits the use of Novavax's...
Turn Biotechnologies Reports Historic Skin Cell Rejuvenation Breakthroughs at ESDR this Week
Company will present data from its successful rejuvenation of fibroblasts and keratinocytes to influential gathering of international dermatologists MOUNTAIN VIEW, Calif., Sept. 4, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and...
H5 influenza vaccines: What needs to be done to reduce the risk of a pandemic
As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential...
Related Services